| Financial Year |
March 31 2023 |
| Monetary Funds |
5,785,354,174.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
279,882,499.25 |
| Accounts Receivable |
8,747,805,078.92 |
| Advances to Suppliers |
2,184,541,487.72 |
| Other Receivables |
1,092,015,478.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,020,324,317.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
222,434,412.33 |
| Total Current Assets |
24,055,739,023.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
498,996,530.57 |
| Investment Properties |
1,207,273,900.00 |
| Fixed Assetes |
1,559,008,116.71 |
| Under-construction Projects |
129,916,376.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
664,150,400.69 |
| R&D expenses |
-- |
| Goodwill |
5,649,706.92 |
| Long-Term Deferred and Prepaid Expenses |
84,284,410.16 |
| Deferred Income Tax Assets |
134,992,928.87 |
| Other Non-Current Assets |
170,762,187.49 |
| Sub-Total of Non-Current Assets |
4,626,250,631.96 |
| Total Assets |
28,681,989,655.27 |
| Short-Term Loans |
1,350,631,614.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,319,312,374.97 |
| Accounts Payable |
2,354,548,170.89 |
| Accounts Received In Advance |
8,342,818.40 |
| Employee Compensation Payable |
35,475,597.67 |
| Taxes Payable |
121,930,437.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,526,506,976.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
240,439,456.14 |
| Other Current Liabilities |
786,606,395.92 |
| Sub-Total of Current Liabilities |
17,776,358,001.06 |
| Long-term Loans |
448,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
108,162,279.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,261,627.81 |
| Deferred Income Tax Liabilities |
178,823,259.22 |
| Other Non-Current Liabilities |
291,070,000.00 |
| Sub-Total of Non-Current Liabilities |
1,249,905,907.49 |
| Total Liabilities |
19,026,263,908.55 |
| Paid-In Capital(Or Share Stock) |
6,050,353,641.00 |
| Capital Surplus |
69,395.46 |
| Surplus Reserve |
303,299,696.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,782,015,456.22 |
| Minority Stockholder's Interest |
1,060,426,987.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,595,298,759.69 |
| Owner's Equity（Stockholder's Equity） |
9,655,725,746.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,681,989,655.27 |
